Posts in category Healthcare


Ocular Therapeutix Inc (OCUL) Gets A Bullish Vote Following 2Q:17 Update

Ocular Therapeutix Inc (NASDAQ:OCUL) shares are on a roughly 4% dip today after the biotech …

Read more

What You Need To Know About Galena Biopharma Inc (GALE) Merger With SELLAS; Maxim Shines Light

Yesterday, Galena Biopharma Inc (NASDAQ:GALE) and SELLAS Life Sciences announced they have entered into an …

Read more

ACADIA Pharmaceuticals Inc. (ACAD) Nuplazid on a Roll, Marvels Cowen

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) shares are shooting up almost 17% with investors clearly paying keen …

Read more

What Analysts Are Saying About Biotech Stocks Achillion Pharmaceuticals, Inc. And ACADIA Pharmaceuticals Inc.

Achillion Pharmaceuticals, Inc. Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) shares are rising about 25% in Wednesday’s trading …

Read more

This Top Analyst Says Avinger Inc (AVGR) Must Find a Buyer ASAP

Avinger Inc (NASDAQ:AVGR) released second-quarter earnings last evening that have left top analyst Jason Mills …

Read more

Valeant Pharmaceuticals Intl Inc Not Quite Through the Woods Yet, Kite Pharma Vaulting to Green Light

Valeant’s Strengths Are Laced with Challenges Valeant Pharmaceuticals Intl Inc (NYSE:VRX) delivered a sound second-quarter …

Read more

Mizuho Still Not Expecting a Turnaround for Valeant Pharmaceuticals Intl Inc (VRX), Neutral on Depomed (DEPO)

Mizuho analyst Irina Rivkind Koffler came out today with new research notes on a handful …

Read more

Cantor Counts on GW Pharmaceuticals PLC- ADR (GWPH) Upcoming Catalysts

GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH) shares were falling 2% yesterday after the biotech company handed …

Read more

Myokardia Inc (MYOK) Heart Drug Takes Next Beat Towards Finish Line; Cowen Boosts Price Target

Upon releasing positive data for lead drug candidate Mavacamten on Monday, investors flocked to Myokardia …

Read more

All Eyes on Valeant Pharmaceuticals Intl Inc (VRX) Earnings, Bedlam for Teva Pharmaceutical (TEVA)

Valeant’s a Deep Shade of Grey All eyes are on Valeant Pharmaceuticals Intl Inc (NYSE:VRX) …

Read more